XNYS · BIO
+4.50% · +$14.98 · Vol 520.3K
After hours · updated 16:10:00 ET
Bio-Rad Laboratories, Inc.Class A

Bio-Rad Laboratories, Inc.Class A

LABORATORY ANALYTICAL INSTRUMENTS
$347.86
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
BIO
Bio-Rad Laboratories, Inc.Class A
Stale score · Tue Aug 4 · completed session · 23h old · Scheduled each trading day · Markets closed · resumes Thu 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

71/ 100
Veridion Score
BUY BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: HIGH · 6/6 factors with data · Stale score · Tue Aug 4 · completed session · 23h old · Scheduled each trading day · Markets closed · resumes Thu 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is BIO moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading BIO catalysts
About Bio-Rad Laboratories, Inc.Class A
LABORATORY ANALYTICAL INSTRUMENTS
Listed since
1980
Employees
7K
Country
US

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$340.00
Day high
$352.63
Day low
$329.60
Previous close
$332.88
52W high
$352.63
-1.35% from high
52W low
$241.71
96% of range
Market cap
$8.9B
P/E
54.85×
EPS
$-38.9600
Beta
0.60
Shares out
26.8M
Volume
520.3K
1.62× rel vol
Avg volume
320.7K
VWAP
$345.39
Price history computed in-house
1W
+6.30%
1M
+17.86%
3M
+35.19%
1Y
+27.81%
YTD
+14.81%
SMA 50 $302.27 · above
SMA 200 $296.15 · above
52W position 96%

BIO overview

Loading financial statements
Loading BIO Form 4 filings
Public disclosures

Congress activity in BIO

Federal contracts

BIO contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BIO in this window.
Lobbying spend

BIO lobbying filings, year to date.

Registered lobbying filings matched to Bio-Rad Laboratories, Inc.Class A.

$240.0K
Refresh interval: 12hSource: LDA disclosure filings
Health Issues Defense Medicare/Medicaid
Filing
$80.0K
BIO-RAD LABORATORIES

FORBES-TATE

Jul 20, 2026
Filing
$80.0K
BIO-RAD LABORATORIES

FORBES-TATE

Apr 17, 2026
Filing
$80.0K
BIO-RAD LABORATORIES

FORBES-TATE

Jan 18, 2026
Loading news for BIO
Analyst ratings
Sovereign unlock shows live analyst consensus for BIO.
Options
Sovereign unlock shows live options positioning for BIO.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.